Our November 2019 edition is live

Our November issue includes partnering companies focused on infectious diseases, specifically viral diseases such as influenza among others.

Go to the profile of Raveena Bhambra
Nov 05, 2019
0
0

In a month where we say 'Happy 150th birthday' to Nature. Our November issue includes partnering companies focused on infectious diseases, specifically viral diseases such as influenza among others.

The editorial features cover the biopharmas targeting common viral denominators to battle flu and the art of closing a biopharma deal.  

Read the full issue here.

Go to the profile of Raveena Bhambra

Raveena Bhambra

Editor, BioPharma Dealmakers , Nature Publishing Group

Hello all, I am the Editor of BioPharma Dealmakers, a quarterly publication that assists companies in identifying potential partners in the pharmaceutical and biotechnology industry and appears in both Nature Biotechnology and Nature Reviews Drug Discovery. I am very passionate about the biopharma industry and have over 12 years of experience of working in the field, specifically in dealmaking, partnering and licensing. In my previous roles I have conducted partner searches identifying both products/technologies and partners for clients, and have edited and written dealmaking-focused reports.

No comments yet.